| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 46.17 | 6.7% | 3.4% |
| Total Income | 46.82 | 7.4% | 3.3% |
| Expenditure | 43.79 | 8.8% | 0.2% |
| PBT | 3.03 | 8.7% | 35.7% |
| Net Profit | 2.21 | 10.6% | 37.3% |
| OPM | 9.24% | 1.88pp | 4.28pp |
| NPM | 4.73% | 0.95pp | 2.57pp |
| EPS | 1.60 | 10.1% | 37.0% |
Denis Chem Lab Ltd Announces Q3 2025 Unaudited Financial Results with a 6.25% YoY Revenue Growth
13 Nov 2025 · 13 Nov 2025, 03:33 pm
Summary
Denis Chem Lab Ltd, a manufacturers of parenteral products, has announced its unaudited financial results for the quarter ended on 30th September, 2025. The company has reported a 6.25% YoY revenue growth. The Board of Directors took on record the Unaudited Financial Results for the quarter ended on 30th September, 2025.
Key Highlights
- 1
Q3 2025 revenue of Rs. 4,617.13 lakh
- 2
6.25% YoY revenue growth
- 3
Half Year ended on 30-06-2025 revenue of Rs. 4,327.59 lakh
- 4
30-09-2024 revenue of Rs. 4,781.76 lakh
- 5
Profit before tax of Rs. 470.58 lakh
- 6
Profit for the period of Rs. 353.06 lakh
- 7
Earnings Per Share of Rs. 10/- each (for continuing operations) - Basic: 2.54
- 8
Total Comprehensive Income for the period of Rs. 225.56 lakh
Management Comments
Denis Chem Lab Ltd
The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2025.
Informational and educational content only. Not investment advice.